(VIANEWS) – NAVAMEDIC (NAVA.OL), ABN AMRO BANK N.V. (ABN.AS), SPBK1 HELGELAND (HELG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 26.86. Meaning, the purchaser of the share is investing kr26.86 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr31.70 at 07:20 EST, way under its 52-week high of kr43.60 and above its 52-week low of kr29.20.
More news about NAVAMEDIC.
2. ABN AMRO BANK N.V. (ABN.AS)
17.2% sales growth and 10.93% return on equity
ABN AMRO Bank N.V. provides various banking products and services to retail, private, and business clients in the Netherlands and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company provides savings and deposits products; labelled residential mortgage products under the Florius brands; and consumer loans under the Alpha Credit Nederland, Credivance, Defam, Moneyou, and ABN AMRO brands. It also issues, promotes, manages, and processes credit cards; provides revolving credit card facilities and pension schemes, as well as consumer credit and mortgages; and life and non-life insurance products. In addition, it offers asset-based solutions, including working capital solutions, equipment leases and loans, and vendor lease services; private banking and wealth-management-related services; and derivatives and equity clearing services. ABN AMRO Bank N.V. was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ABN AMRO BANK N.V. has a trailing twelve months EPS of €2.71.
PE Ratio
ABN AMRO BANK N.V. has a trailing twelve months price to earnings ratio of 4.91. Meaning, the purchaser of the share is investing €4.91 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.93%.
Moving Average
ABN AMRO BANK N.V.’s value is below its 50-day moving average of €14.46 and below its 200-day moving average of €14.41.
Yearly Top and Bottom Value
ABN AMRO BANK N.V.’s stock is valued at €13.31 at 07:20 EST, way below its 52-week high of €17.00 and way higher than its 52-week low of €8.69.
More news about ABN AMRO BANK N.V..
3. SPBK1 HELGELAND (HELG.OL)
13.5% sales growth and 10.78% return on equity
SpareBank 1 Helgeland provides various financial products and services to retail customers, small and medium enterprises, municipal authorities, and institutions in Norway. The company operates in two segments, Retail Market and Corporate Market. It offers savings, investment, and insurance products, as well as leasing and mortgage services. The company is also involved in owning, managing, and letting commercial properties. It operates through branches located in Mosjøen, Brønnøysund, and Sandnessjøen. The company was founded in 1860 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, SPBK1 HELGELAND has a trailing twelve months EPS of kr14.8.
PE Ratio
SPBK1 HELGELAND has a trailing twelve months price to earnings ratio of 8.24. Meaning, the purchaser of the share is investing kr8.24 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.78%.
Yearly Top and Bottom Value
SPBK1 HELGELAND’s stock is valued at kr122.00 at 07:20 EST, way under its 52-week high of kr140.00 and way higher than its 52-week low of kr103.00.
Moving Average
SPBK1 HELGELAND’s worth is below its 50-day moving average of kr125.04 and under its 200-day moving average of kr122.75.
More news about SPBK1 HELGELAND.
4. LERØY SEAFOOD GP (LSG.OL)
12.1% sales growth and 3.73% return on equity
Lerøy Seafood Group ASA produces, processes, markets, sells, and distributes seafood products worldwide. It operates in three segments: Wildcatch; Farming; and Value-Added Processing, Sales and Distribution. The company offers smoked and gravad salmon, and trout products; farmed and wild catch whole fishes; fillets and portions; ready-to-eat and ready-to-cook products; fish blocks and cubes; breaded products; pre-fried fish burgers and patties; crustaceans and molluscs; seaweeds; and other products. Lerøy Seafood Group ASA markets its products primarily under the Norway Seafoods, Arctic Supreme, Fjord trout, Aurora Salmon, Fossen, Sea Eagle, Lerøy, and M?r brands to shops, restaurants, canteens, and hotels. The company was founded in 1899 and is headquartered in Bergen, Norway. Lerøy Seafood Group ASA is a subsidiary of Austevoll Seafood ASA.
Earnings Per Share
As for profitability, LERØY SEAFOOD GP has a trailing twelve months EPS of kr1.02.
PE Ratio
LERØY SEAFOOD GP has a trailing twelve months price to earnings ratio of 43.12. Meaning, the purchaser of the share is investing kr43.12 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.73%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 32.3% and positive 31.6% for the next.
Sales Growth
LERØY SEAFOOD GP’s sales growth is 7.1% for the current quarter and 12.1% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
LERØY SEAFOOD GP’s EBITDA is 1.15.
Yearly Top and Bottom Value
LERØY SEAFOOD GP’s stock is valued at kr43.98 at 07:20 EST, way under its 52-week high of kr66.90 and way above its 52-week low of kr38.40.
More news about LERØY SEAFOOD GP.
5. MOWI (MOWI.OL)
10% sales growth and 10.75% return on equity
Mowi ASA, a seafood company, produces and supplies farmed salmon products worldwide. It operates through three segments: Feed, Farming, and Sales and Marketing. The company is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. It offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. The company also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. It offers its products under the Mowi, Mowi Salmon, Donegal Silver, Admiral's, Pieters, Laschinger, Kritsen, Ducktrap River, Harbour Salmon Co., Rebel Fish, Supreme Salmon, Olav's, Northern Harvest, and Mowi Nutrition brand names. The company was formerly known as Marine Harvest ASA and changed its name to Mowi ASA in December 2018. Mowi ASA was founded in 1964 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, MOWI has a trailing twelve months EPS of kr8.4.
PE Ratio
MOWI has a trailing twelve months price to earnings ratio of 22.77. Meaning, the purchaser of the share is investing kr22.77 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.75%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MOWI’s EBITDA is 23.26.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 1, 2023, the estimated forward annual dividend rate is 8 and the estimated forward annual dividend yield is 4.17%.
More news about MOWI.
6. MAREL (MAREL.AS)
5.5% sales growth and 4.51% return on equity
Marel hf. develops, distributes, and sells solutions, software, and services to food processing industries in Europe, the Middle East, Africa, the Americas, Asia, and Oceania. The company's Poultry Processing segment offers integrated systems, software, and services for processing broilers, turkeys, and ducks. Its Meat Processing segment supplies primary, secondary, and further processing equipment, systems, software, and services of pork, beef, veal, and sheep. The company's Fish Processing segment offers equipment, systems, software, and services for farmed and wild salmon and whitefish processing. Its Plant, pet and feed segment provides solutions and services to the pet food, plant-based protein, and aqua feed markets. Marel hf. was founded in 1977 and is based in Garðabær, Iceland.
Earnings Per Share
As for profitability, MAREL has a trailing twelve months EPS of €0.05.
PE Ratio
MAREL has a trailing twelve months price to earnings ratio of 64.2. Meaning, the purchaser of the share is investing €64.2 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.51%.
Sales Growth
MAREL’s sales growth is 20.4% for the ongoing quarter and 5.5% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.4%, now sitting on 1.78B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MAREL’s EBITDA is 80.54.
More news about MAREL.
